J9003 – Leuprolide injectable (camcevi etm), 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9003
- Long description
- Leuprolide injectable (camcevi etm), 1 mg
- Short description
- Leupro inj, camcevi etm, 1mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- Added
- April 1, 2026
- Last change
- April 1, 2026 – No change
Frequently asked questions
What is HCPCS code J9003?
J9003 is a HCPCS Level II code for leuprolide injectable (camcevi etm), 1 mg.
Does Medicare cover J9003?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J8612 – Methotrexate (xatmep), oral, 2.5 mg
- J8650 – Nabilone, oral, 1 mg
- J8655 – Netupitant 300 mg and palonosetron 0.5 mg, oral
- J8670 – Rolapitant, oral, 1 mg
- J8700 – Temozolomide, oral, 5 mg
- J8705 – Topotecan, oral, 0.25 mg
- J8999 – Prescription drug, oral, chemotherapeutic, nos
- J9000 – Injection, doxorubicin hydrochloride, 10 mg
- J9010 – Injection, alemtuzumab, 10 mg
- J9011 – Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 – Injection, aldesleukin, per single use vial
- J9017 – Injection, arsenic trioxide, 1 mg
- J9019 – Injection, asparaginase (erwinaze), 1,000 iu
- J9020 – Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 – Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 – Injection, atezolizumab, 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.